End Cash: The amount of cash held by the company for the given period.
NovoCure Limited (NVCR) had End Cash of $103.39M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$655.35M |
|
$-136.23M |
|
$166.88M |
|
$488.47M |
|
$809.15M |
|
$-153.80M |
|
$17.55M |
|
$-136.25M |
|
$-136.25M |
|
$-136.23M |
|
$-136.23M |
|
$-136.23M |
|
$-136.23M |
|
$-153.80M |
|
$-162.41M |
|
111.47M |
|
111.47M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$646.73M |
|
$99.67M |
|
$157.59M |
|
$804.33M |
|
$223.23M |
|
$236.69M |
|
$240.63M |
|
$463.86M |
|
$340.47M |
|
$340.47M |
|
$340.47M |
|
112.49M |
|
| Cash Flow Statement Financials | |
$-49.03M |
|
$437.28M |
|
$-451.34M |
|
$166.09M |
|
|
End Cash |
$103.39M |
$-62.70M |
|
$104.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.90 |
|
-- |
|
-- |
|
0.41 |
|
0.70 |
|
74.54% |
|
-23.47% |
|
-23.47% |
|
-24.78% |
|
-20.79% |
|
-20.79% |
|
$-75.68M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
4.06 |
|
4.42 |
|
82.49 |
|
-40.01% |
|
-40.01% |
|
-16.94% |
|
-23.60% |
|
$3.03 |
|
$-0.68 |
|
$-0.44 |
|